Earthquake early warning moves forward in four central American countries
Scienmag
APRIL 21, 2022
The project—Alerta Temprana de Terremotos en América […].
Scienmag
APRIL 21, 2022
The project—Alerta Temprana de Terremotos en América […].
The Pharma Data
APRIL 28, 2021
De laatste handelsdag van de Aandelen aan Euronext Amsterdam en Euronext Brussel (“ Euronext “) zal op 24 mei 2021 zijn en de notering van en de handel in de Aandelen zal eindigen per 25 mei 2021. Overdracht van de Aandelen en betaling van de Biedprijs zal plaatsvinden op 3 mei 2021. ING Bank N.V.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
APRIL 26, 2021
De laatste datum waarop de Aandelen kunnen worden verhandeld aan Euronext Amsterdam en Euronext Brussel (‘’ Euronext ’’) zal op 24 mei 2021 zijn, en de notering van en de handel in de Aandelen zal eindigen op 25 mei 2021. a) ( Intentions following the Offer being declared unconditional ) en Hoofdstuk 6.11(b)
pharmaphorum
AUGUST 10, 2020
The new tool can be used by labs to support their own COVID-19 research projects on their local patient base, and in turn could be used by pharma companies that are developing candidates vaccines and antiviral therapies. The post Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’ appeared first on.
pharmaphorum
AUGUST 17, 2020
Kiadis has joined forces with five Dutch biomedical groups on the R&D for its coronavirus candidate – called K-NK-ID101 – and has already submitted a grant application to the US government to try to raise money for the project. The new COVID-19 project extends the use of Kiadis’ NK platform into infectious diseases for the first time.
pharmaphorum
AUGUST 28, 2020
“When we look at devices that track and measure our health, we’re hyper-focused on the physical elements like activity, weight, or sleep,” writes Amazon’s principal medical officer for the Halo project, Dr Maulik Majmudar, in a blog post. But while these are important, they don’t make up the full picture.
pharmaphorum
FEBRUARY 24, 2021
The health economic component of the revamped IPTs is informed by guidelines from the Grupo de Evaluación de Novedades, EStandarización e Investigación en Selección de Medicamentos (Group for the Evaluation of Innovations, Standardisation and Research in Drug Selection, GENESIS).
Let's personalize your content